InvestorsHub Logo
Followers 64
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

Re: coinstarz post# 1770

Tuesday, 05/23/2006 7:51:46 PM

Tuesday, May 23, 2006 7:51:46 PM

Post# of 6489
possible pricing -

I would expect easily $25k then, and rising every year. It's not possible to reach every patient, and TRCA will snare a few. But 3,000-4,000 within a couple of years does not seem at all a stretch. So maybe $100m on-label.

Does anyone think that off-label sales will begin immediately (in primary, rather than severe - yes I know there are other indications, but am thinking of the endos only for now) ? Any hard evidence in the endos' sphere ?

"....on the biotech battle-field, you need some élan...."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News